Viewpoint Molecular Targeting
Coralville, US
Biotech
Founders & leadership
CN
Curtis NelsonDirector
HC
Heyward ColemanExecutive Officer, Director
FJ
Frances JohnsonExecutive Officer, Director
MS
Michael SchultzExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$14.3MraisedJan 2021 · 29 investors · Biotechnology
Rule 506(b)$750KraisedJun 2020 · 10 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.